First results of Russian coronavirus vaccine trial may include data from 5,000-10,000 people

The Sputnik V trial, involving 40,000 volunteers, has been underway in Moscow since the beginning of September.

Preliminary results from the late-stage human trial of Russia's main coronavirus vaccine candidate could include data from 5,000-10,000 participants, Denis Logunov, a director at the Gamaleya Institute that developed the vaccine, said on Monday.